B1F, Room of “Hojyu”

10:20-10:25  Opening Remarks

• Sidney Smith Jr.
  University of North Carolina at Chapel Hill Past President, World Heart Federation; Past President, American Heart Association

10:25-11:45  Cardiomyopathy, Myocarditis and Heart Failure

Chair

• Toshio Shimada
  Shizuoka General Hospital Clinical Research Center, Japan
  
• Koji Hasegawa
  National Hospital Organization Kyoto Medical Center, Japan

Speaker

• Akira Matsumori
  National Hospital Organization Kyoto Medical Center, Japan
  Infectious Immune Mechanisms of Myocarditis and Cardiomyopathies:
  Past, Present and Future- In Memory of Professor Chuichi Kawai
• Leslie T Cooper Jr,
  Mayo Clinic, Jacksonville, USA
  The ACC Expert Decision Care Pathway Stages and Management Changes
• Tohru Izumi,
  Kitasato University/Niigata Minami Hospital, Japan
  DOPPO Rehabilitation for Octogenarian with Heart Failure
• Peter Liu,
  University of Ottawa and University of Toronto, Canada
  Myocarditis: from Coxsackie to COVID – an Onward Journey

11:45-12:00  Lunch box provision/distribution

12:00-13:00  Luncheon Seminar by Bayer Pharma Japan

Bidirectional Links Between Cardio-Renal and Metabolic Diseases:
Underlying Evidence and Implications for Management

13:05-14:05  Cardiomyopathy and Heart Failure

Chair

• Peter Liu,
  University of Ottawa and University of Toronto, Canada
  
• Masashi Komeda
  Fukuda General Hospital Japan

Speaker

• Sivadasanpillai Harikrishnan
  Sree Chitra Tirunal Institute for Medical Sciences and Technology, India
  Endomyocardial Fibrosis – Vanishing entity?
• Tatsuya Morimoto
  University of Shizuoka, School of Pharmaceutical Sciences. Japan
  Novel Heart Failure Therapy targeting signaling pathways in cardiomyocytes.
• Jianzeng Dong
  Beijing Anzhen Hospital, Capital Medical University, China
  Interaction Between Heart Failure and Atrial Fibrillation

14:05-14:20  Coffee Break

14:20-15:20  Coffee Break Seminar I by Bristol-Myers Squibb

Management of Obstructive Hypertrophic Cardiomyopathy
－What is new in 2024 AHA/ACC Guideline? －

15:25-16:25  Heart Failure and Cardiovascular Surgery

Chair

• Sivadasanpillai Harikrishnan
  Sree Chitra Tirunal Institute for Medical Sciences and Technology, India

• Tatsuya Morimoto
  University of Shizuoka, School of Pharmaceutical Sciences. Japan

Speaker

• Hisayoshi Suma,
  Medock Healthcare Clinic Tokyo Japan
  The Rise and Fall of Ventriculoplasty for Heart Failure
• Öztekin Oto
  President, Heart and Health Foundation of Turkey
  Cardiovascular Surgery for Heart Failure: What can We Do?
• Masashi Komeda
  Fukuda General Hospital Japan
  Surgical Treatment for DCM and HCM/HOCM

16:25-16:40   Coffee Break

16:40-17:40   Coffee Break Seminar II by Novartis Pharma

Lipids and Lipoproteins in ischemic heart disease:
from mechanistic insights to therapeutic targeting

17:45-18:25   For Cardiovascular Health in the World

Chair

• Akira Matsumori
  National Hospital Organization Kyoto Medical Center, Japan
• Sidney Smith Jr..
  University of North Carolina at Chapel Hill

Speaker

• Sidney Smith Jr..
  University of North Carolina at Chapel Hill
  AHA Second Century Vision: Advancing Quality Improvement Heart Failure Work in Asia
• Koji Hasegawa
  National Hospital Organization Kyoto Medical Center
  Pharmacotherapy for HFpEF in Different Region of the World

18:25-18:30  Closing Remarks

• Akira Matsumori
  National Hospital Organization Kyoto Medical Center, Japan

1F Room of “CUDDY COURT”

19:15-19:45  General Abstract Award Competition

Judge Committee Chair:

• Masatoshi Fujita
  Uji Hospital